Neonicotinoids chemical review

Active constituents, product registrations, and label approvals for neonicotinoids (acetamiprid, clothianidin, dinotefuran, imidacloprid, thiacloprid, thiamethoxam) were nominated for review following identification of new environmental risks in 2019. As a result of the limited use pattern (in companion animals), and formulation (as oral tablets), the registered products and approved active constituent containing nitenpyram are considered to be outside the scope of this review.

The review was prioritised based on consideration of key criteria.

The APVMA commenced the review of active constituents, product registrations, and label approvals in November 2019. The scope of the review was confined to environment and worker safety. The scope was outlined in the Gazette on 19 November 2019.

The total legislated timeframe for the review is 42 months, beginning in February 2020 and ending in August 2023.

The s 32 notice of reconsideration was sent to holders and nominated agents upon commencement of the review and published in the Gazette on 19 November 2019.

The public consultation on the scope and work plan was open for submissions from 19 November 2019 until 3 February 2020. The end of the public consultation on the work plan and scope is the beginning of the review timeframe.